The House of Representatives engaged in debate and consideration of legislation aimed at combating the trafficking of fentanyl and fentanyl-related substances.
Summary of the House proceedings
H.R. 27 was called up for consideration to amend the Controlled Substances Act regarding the scheduling of fentanyl-related substances.
H.R. 27 seeks to permanently place fentanyl-related substances into schedule I of the Controlled Substances Act to empower law enforcement to prosecute drug traffickers.
H.R. 27 provides for expedited registration processes for practitioners conducting certain research with schedule I substances.
H.R. 27 allows for a single registration for related research sites under specific conditions.
H.R. 27 modifies inspection requirements when a person applies for registration to conduct research with a second controlled substance in the same or higher numerical schedule.
H.R. 27 allows for the continuation of research on substances newly added to schedule I for a limited period.
H.R. 27 permits certain small-scale manufacturing activities to be treated as coincident to research.
H.R. 27 requires the Attorney General to make public the process and criteria for research applications that differ from standard processes for substances in the same schedule.
H.R. 27 includes technical corrections to (Public Law 117-328).
H.R. 27 mandates the Attorney General to issue implementing rules within 6 months of enactment.
H.R. 27 amends the Controlled Substances Act and the Controlled Substances Import and Export Act to include penalties for fentanyl-related substances.
Summary of Senate proceedings
There was no Senate activity on this date.
Written by an AI model from that day's Congressional Record, not by a person. .